Want to see JP:219A full AI Analyst Report?

Heartseed, Inc. (219A) Price & Analysis

5 Followers

219A Stock Chart & Stats

¥1804.00

-¥95.00(-2.73%)

At close: Jan 08 4:00 PM EST

¥1804.00

-¥95.00(-2.73%)

Day’s Range― - ―

52-Week Range¥1,343.00 - ¥3,855.00

Previous CloseN/A

Volume1.41M

Average Volume (3M)411.72K

Market Cap

¥52.73B

Enterprise Value¥31.86K

Total Cash (Recent Filing)¥7.34B

Total Debt (Recent Filing)¥890.00K

Price to Earnings (P/E)―

Beta0.90

Next Earnings

Nov 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)25.93

Shares Outstanding22,897,400

10 Day Avg. Volume613,260

30 Day Avg. Volume411,716

Financial Highlights & Ratios

PEG Ratio-2.00

Price to Book (P/B)5.17

Price to Sales (P/S)12.93

P/FCF Ratio37.21

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-94.5

Revenue Forecast (FY)¥451.00M

Bulls Say, Bears Say

Bulls Say

FY2025 Profitability TurnaroundThe sharp FY2025 revenue and earnings inflection indicates improved commercial execution and operating leverage. If maintained, the stronger profit base can support internal funding and reduce dependence on external capital.

Low Financial LeverageMinimal leverage limits interest and refinancing risk while preserving financial flexibility. A strong equity base gives Heartseed greater capacity to fund development activities and absorb setbacks without balance-sheet stress.

Positive Free Cash FlowPositive operating and free cash flow, closely tracking reported profits, improves the quality of FY2025 earnings. Sustained cash conversion would strengthen self-funding capacity and reduce future reliance on financing.

Bears Say

History Of Losses And Cash BurnThe multi-year loss and cash-burn period shows that profitability has not yet been proven through a full operating cycle. A renewed downturn could again increase funding needs and pressure the company's financial flexibility.

Earnings Comparability RiskInconsistent gross-profit disclosure makes it harder to assess underlying margins, cost structure and operating leverage. This limits confidence in trend analysis and complicates evaluation of whether FY2025 profitability is repeatable.

Profitability SustainabilityThe latest cash generation is encouraging but follows several years of negative performance, leaving execution risk elevated. Durable value creation will depend on converting the FY2025 improvement into consistent recurring profits and cash flow.

Heartseed, Inc. News

Heartseed Secures ¥2 Billion Credit Line to Advance Heart Failure Cell Therapy

Heartseed, Inc. ( ($JP:219A) ) has provided an update. Heartseed Inc. has secured a 2 billion yen special...

29d ago

219A

Heartseed Books Subsidy-Driven Non-Operating Gain Without Changing Outlook

Heartseed, Inc. ( ($JP:219A) ) just unveiled an announcement. Heartseed Inc. reported non-operating income of 69,833 thousand yen...

29d ago

219A

Heartseed posts interim loss but keeps strong equity base as R&D weighs on 2026 outlook

Heartseed, Inc. ( ($JP:219A) ) has provided an update. Heartseed Inc. reported non-consolidated net sales of ¥467 million...

29d ago

219A

Heartseed doses first patient in EMERALD trial of HS-005 for dilated cardiomyopathy

Heartseed, Inc. ( ($JP:219A) ) just unveiled an announcement. Heartseed Inc. has begun dosing patients in its domestic...

3M ago

219A

Heartseed Advances HS-001 Heart Failure Therapy Toward Japan Approval After Positive Trial Readout

Heartseed, Inc. ( ($JP:219A) ) has issued an update. Heartseed Inc. reported results from its Phase I/II LAPiS...

3M ago

219A

Heartseed Narrows Quarterly Loss but Projects Deeper Full-Year Deficit

Heartseed, Inc. ( ($JP:219A) ) has provided an announcement. Heartseed Inc. reported non-consolidated net sales of ¥465 million...

4M ago

219A

Heartseed launches post-delivery RSU plan to align board pay with shareholder value

Heartseed, Inc. ( ($JP:219A) ) has shared an announcement. Heartseed Inc. has approved the grant of post-delivery restricted...

5M ago

219A

Heartseed revamps governance with new executive officer system and board changes

Heartseed, Inc. ( ($JP:219A) ) has provided an update. Heartseed Inc. announced it will introduce an executive officer...

7M ago

219A

Heartseed Issues Cautionary Notice Alongside FY2025 Financial Results

Heartseed, Inc. ( ($JP:219A) ) has shared an announcement. Heartseed Inc. has released an informational document presenting its...

7M ago

219A

Heartseed Swings to Profit in 2025 but Signals Return to Loss on Higher 2026 Investment

Heartseed, Inc. ( ($JP:219A) ) has provided an update. Heartseed Inc. reported non-consolidated net sales of ¥3,026 million...

7M ago

219A

219A FAQ

What was Heartseed, Inc.’s price range in the past 12 months?

Heartseed, Inc. lowest stock price was ¥1343.00 and its highest was ¥3855.00 in the past 12 months.

What is Heartseed, Inc.’s market cap?

Heartseed, Inc.’s market cap is ¥52.73B.

When is Heartseed, Inc.’s upcoming earnings report date?

Heartseed, Inc.’s upcoming earnings report date is Nov 13, 2026 which is in 62 days.

How were Heartseed, Inc.’s earnings last quarter?

Heartseed, Inc. released its earnings results on Aug 14, 2026. The company reported -¥21.7 earnings per share for the quarter.

Is Heartseed, Inc. overvalued?

According to Wall Street analysts Heartseed, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Heartseed, Inc. pay dividends?

Heartseed, Inc. does not currently pay dividends.

What is Heartseed, Inc.’s EPS estimate?

Heartseed, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Heartseed, Inc. have?

Heartseed, Inc. has 22,897,400 shares outstanding.

What happened to Heartseed, Inc.’s price movement after its last earnings report?

Heartseed, Inc. reported an EPS of -¥21.7 in its last earnings report. Following the earnings report the stock price went down -0.103%.

Which hedge fund is a major shareholder of Heartseed, Inc.?

Currently, no hedge funds are holding shares in JP:219A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Heartseed, Inc.

Heartseed Inc. is a Japan-based company engaged in research and development of regenerative medicine products. The company has established cardiac regenerative medicine, a therapy in which microtissue derived from iPS cells is transplanted into the heart for patients with severe heart failure. Target diseases include dilated cardiomyopathy, old myocardial infarction, and dilated-phase hypertrophic cardiomyopathy.